Patent details

Basic Information

Publication number:

EP2996772

PCT Application Number:

US2014037761

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147984736

PCT Publication Number:

WO2014186310

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR THE TREATMENT OF NEURODEGENERATION

French Title of Invention:

MÉTHODES DE TRAITEMENT DE LA NEURODÉGÉNÉRESCENCE

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG VON NEURODEGENERATION

SPC Number:

Dates

Filing date:

13/05/2014

Grant date:

19/12/2018

EP Publication Date:

23/03/2016

PCT Publication Date:

20/11/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/12/2018

EP B1 Publication Date:

19/12/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/05/2019

Expiration date:

13/05/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2018

 

 

Name:

Momenta Pharmaceuticals, Inc.

Address:

301 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

BOSQUES, Carlos, J.

Address:

United States (US)

2

Name:

PROD'HOMME, Thomas, E.

Address:

United States (US)

3

Name:

KAUNDINYA, Ganesh

Address:

United States (US)

4

Name:

LING, Leona, E.

Address:

United States (US)

5

Name:

MANNING, Anthony

Address:

United States (US)

Priority

Priority Number:

201361822795 P

Priority Date:

13/05/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61P 25/28;

Publication

European Patent Bulletin

Issue number:

201851

Publication date:

19/12/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages